Intra-Cellular Therapies, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid in USD from Q1 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease.
Summary
Intra-Cellular Therapies, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid history and growth rate from Q1 2019 to Q2 2024.
  • Intra-Cellular Therapies, Inc. Lessee, Operating Lease, Liability, to be Paid for the quarter ending June 30, 2024 was $22.7M, a 3.04% decline year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $22.7M -$713K -3.04% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $20.7M -$3.71M -15.2% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $21.6M -$4.74M -18% Dec 31, 2023 10-K 2024-02-22
Q3 2023 $22.5M Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $23.5M Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $24.4M Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $26.4M Dec 31, 2022 10-K 2023-03-01
Q4 2019 $35.2M Dec 31, 2019 10-K 2020-03-02
Q3 2019 $35.1M Sep 30, 2019 10-Q 2019-11-05
Q2 2019 $35.9M Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $37.3M Mar 31, 2019 10-Q 2019-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.